logo
Select company
Select metric
-6.87%Buyback Yield
VS
Market
19
Sector
41
Industry
52
History
31
$ 35.28Close
$ 12.38 - $ 35.37 52-Week Range
Ticker Information

Ticker

ANAB

Company Name

ANAPTYSBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ANAPTYSBIO INC - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ANAB - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-6.87%$ 631.05M$ 43.34M
3/31/2025-15.43%$ 609.06M$ 93.99M
12/31/2024-18.47%$ 502.94M$ 92.88M
9/30/2024-15.38%$ 604.92M$ 93.05M
6/30/20240.6%$ 888.53M$ -5.29M
3/31/20242.51%$ 716.57M$ -17.96M
12/31/20237.61%$ 624.92M$ -47.53M
9/30/202310.31%$ 430.52M$ -44.37M
6/30/20238.54%$ 490.03M$ -41.83M
3/31/20235.32%$ 549.88M$ -29.28M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ANAPTYSBIO INC's latest trailing twelve months (TTM) Buyback Yield stands at -0.26%.
  • Over the past 5 years, ANAPTYSBIO INC's average Buyback Yield has been -1.37%.
  • The median Buyback Yield for ANAPTYSBIO INC during this period was -0.22%
  • ANAPTYSBIO INC reached its highest Buyback Yield over the past 5 years at 10.31%.
  • The lowest Buyback Yield recorded by ANAPTYSBIO INC in the same timeframe -18.47%

ANAPTYSBIO INC's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
PHAT : PHATHOM PHARMACEUTICALS INC -18.51%NAGE : NIAGEN BIOSCIENCE INC -1.56%GYRE : GYRE THERAPEUTICS INC -4.01%CRMD : CORMEDIX INC -14.38%XNCR : XENCOR INC -39.31%TBPH : THERAVANCE BIOPHARMA INC 0.33%ZYME : ZYMEWORKS INC 2.28%KURA : KURA ONCOLOGY INC -0.71%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -0.42%ZVRA : ZEVRA THERAPEUTICS INC -10.44%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for ANAPTYSBIO INC is calculated as follows: (-1 * CF - Equity [ $ 2.13M ]) / Market Cap [ $ 810.32M ]
(=) Buyback Yield [ -0.26% ]

ANAB - Buyback Yield, Last 5 years

-18.47%

Minimum

Dec 31, 2024

10.31%

Maximum

Sep 30, 2023

-1.37%

Average

-0.22%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.46%
average0.64%
median0.01%
std2.71%